Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Davis

Showing results (151-160 of 400) with videos related to

Pageof 40
Sort By:
Neurology|February 1, 1988
Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generationsJ C Breitner, J M Silverman, R C Mohs, et al.
Life Sciences|October 1, 1977
Neurotransmitter metabolites in the cerebrospinal fluid of man following physostigmineK L Davis, L E Hollister, F K Goodwin, et al.
The Journal of Biological Chemistry|August 24, 1999
An erythropoietin fusion protein comprised of identical repeating domains exhibits enhanced biological propertiesA J Sytkowski, E D Lunn, M A Risinger, et al.
Biological Psychiatry|April 1, 1985
Red blood cell choline. II: Kinetics in Alzheimer's diseaseP D Kanof, B S Greenwald, R C Mohs, et al.
Journal of Neurotrauma|September 3, 1998
Mild traumatic brain injury does not modify the cerebral blood flow profile of secondary forebrain ischemia in Wistar ratsK L Davis, L W Jenkins, D S DeWitt, et al.
Archives of General Psychiatry|May 1, 1987
Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of ageR C Mohs, J C Breitner, J M Silverman, et al.
The American Journal of Psychiatry|November 1, 1977
Phenytoin treatment of the binge-eating syndromeB M Wermuth, K L Davis, L E Hollister, et al.
Psychopharmacology Communications|January 1, 1975
Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluationK L Davis, L E Hollister, P A Berger, et al.
Psychopharmacology|December 21, 1976
Physostigmine: effects on cognition and affect in normal subjectsK L Davis, L E Hollister, J Overall, et al.
Pharmacology, Biochemistry, and Behavior|July 1, 1980
MSH and MIF-I in animal models of tardive dyskinesiaK L Davis, A J Kastin, B A Beilstein, et al.
Pageof 40

Showing results (151-160 of 400) with videos related to

Sort By:
Pageof 40
Neurology|February 1, 1988
Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generationsJ C Breitner, J M Silverman, R C Mohs, et al.
Life Sciences|October 1, 1977
Neurotransmitter metabolites in the cerebrospinal fluid of man following physostigmineK L Davis, L E Hollister, F K Goodwin, et al.
The Journal of Biological Chemistry|August 24, 1999
An erythropoietin fusion protein comprised of identical repeating domains exhibits enhanced biological propertiesA J Sytkowski, E D Lunn, M A Risinger, et al.
Biological Psychiatry|April 1, 1985
Red blood cell choline. II: Kinetics in Alzheimer's diseaseP D Kanof, B S Greenwald, R C Mohs, et al.
Journal of Neurotrauma|September 3, 1998
Mild traumatic brain injury does not modify the cerebral blood flow profile of secondary forebrain ischemia in Wistar ratsK L Davis, L W Jenkins, D S DeWitt, et al.
Archives of General Psychiatry|May 1, 1987
Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of ageR C Mohs, J C Breitner, J M Silverman, et al.
The American Journal of Psychiatry|November 1, 1977
Phenytoin treatment of the binge-eating syndromeB M Wermuth, K L Davis, L E Hollister, et al.
Psychopharmacology Communications|January 1, 1975
Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluationK L Davis, L E Hollister, P A Berger, et al.
Psychopharmacology|December 21, 1976
Physostigmine: effects on cognition and affect in normal subjectsK L Davis, L E Hollister, J Overall, et al.
Pharmacology, Biochemistry, and Behavior|July 1, 1980
MSH and MIF-I in animal models of tardive dyskinesiaK L Davis, A J Kastin, B A Beilstein, et al.
Pageof 40